Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
22.38
+0.11 (0.49%)
At close: Sep 30, 2026, 4:00 PM EDT
22.21
-0.17 (-0.76%)
Pre-market: Oct 1, 2026, 4:01 AM EDT
Fresenius Medical Care AG Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Fresenius Medical Care AG stock has a consensus rating of "Hold" and an average price target of $25.28. The average 1-year stock price forecast is 12.96% higher than the current stock price, while the lowest is $17.07 (-23.73%) and the highest is $37.55 (+67.78%).
Price Target: $25.28 (+12.96%)
Analyst Consensus: Hold
Price Target
Chart* Price targets were last updated on Aug 26, 2026.
Analyst Ratings
The average analyst rating for Fresenius Medical Care AG stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 3 | 3 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 2 | 2 | 2 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 7 | 7 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Hold Maintains $25 | Hold | Maintains | $25 | +11.71% | Aug 26, 2026 |
| Bernstein | Bernstein | Hold Maintains $26 → $26 | Hold | Maintains | $26 → $26 | +15.28% | Aug 6, 2026 |
| Exane BNP Paribas | Exane BNP Paribas | Sell Downgrades $20 | Sell | Downgrades | $20 | -11.08% | Jul 28, 2026 |
Financial Forecast
Revenue This Year
19.48B
from 19.63B
Decreased by -0.73%
Revenue Next Year
20.11B
from 19.48B
Increased by 3.22%
EPS This Year
4.06
from 4.28
Decreased by -5.15%
EPS Next Year
4.25
from 4.06
Increased by 4.79%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.